Table 2 Comparison of SDS, IPSS, SF-36 VT, PHQ, and incontinence recovery between the two groups.
Control group (n = 125) | Intervention group (n = 80) | p | |
|---|---|---|---|
SDS | |||
Baseline | 33.0(26.5,41.0) | 58.0(52.0,64.8) | < 0.01 |
One-month follow-up | 23.0(22.0,25.0) | 52.0(45.0,57.8) | < 0.01 |
Three-month follow-up | 23.0(21.0,24.0) | 46.0(41.0,55.8) | < 0.01 |
Six-month follow-up | 22.0(21.0,23.0) | 45.0(41.0,47.0) | < 0.01 |
Change | −12.47 ± 9.87 | −13.82 ± 8.42 | 0.31 |
IPSS | |||
Baseline | 11.0(5.0,13.5) | 10.5(5.0,16.0) | 0.36 |
One-month follow-up | 3.0(1.5,5.0) | 7.0(3.0,10.8) | < 0.01 |
Three-month follow-up | 3.0(1.0,4.0) | 6.0(3.0,7.0) | < 0.01 |
Six-month follow-up | 1.0(0.0,2.0) | 3.0(1.3,4.8) | < 0.01 |
Change | −9.0(−12.5,−4.0) | −8.0(−13.0,−2.0) | 0.24 |
SF-36 VT | |||
Baseline | 47.0(42.0,53.0) | 33.0(28.0,36.8) | < 0.01 |
One-month follow-up | 51.0(46.5,55.0) | 42.0(37.0,46.0) | < 0.01 |
Three-month follow-up | 57.0(52.5,62.0) | 49.5(41.3,54.0) | < 0.01 |
Six-month follow-up | 60.0(53.5,65.0) | 48.0(41.0,55.0) | < 0.01 |
Change | 13.17 ± 9.06 | 15.85 ± 8.38 | < 0.01 |
PHQ | |||
Baseline | 6.0(3.0,11.0) | 9.5(6.0,13.0) | < 0.01 |
One-month follow-up | 4.0(2.0,6.0) | 8.5(5.3,11.0) | < 0.01 |
Three-month follow-up | 3.0(2.0,4.0) | 7.0(4.0,10.0) | < 0.01 |
Six-month follow-up | 3.0(2.0,5.0) | 5.0(3.0,7.0) | < 0.01 |
Change | −4.0(−8.0,0.0) | −5.0(−8.0,−0.3) | 0.71 |
Incontinence recovery | |||
One-month follow-up | 67(53.60) | 27(33.75) | < 0.01 |
Three-month follow-up | 104(83.20) | 50(62.50) | < 0.01 |
Six-month follow-up | 123(98.40) | 67(83.75) | < 0.01 |